42,955 Shares in Indivior PLC (NASDAQ:INDV) Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC acquired a new position in shares of Indivior PLC (NASDAQ:INDV) in the 4th quarter, Holdings Channel.com reports. The fund acquired 42,955 shares of the company’s stock, valued at approximately $649,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Campbell & CO Investment Adviser LLC bought a new position in Indivior during the 3rd quarter worth about $801,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Indivior by 15.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 39,596 shares of the company’s stock valued at $860,000 after acquiring an additional 5,365 shares in the last quarter. Renaissance Group LLC lifted its stake in Indivior by 2.1% in the 3rd quarter. Renaissance Group LLC now owns 97,127 shares of the company’s stock valued at $2,241,000 after acquiring an additional 1,959 shares in the last quarter. Deutsche Bank AG acquired a new position in Indivior during the 3rd quarter worth approximately $3,181,000. Finally, Swiss National Bank grew its stake in shares of Indivior by 1.0% during the 3rd quarter. Swiss National Bank now owns 287,897 shares of the company’s stock worth $6,257,000 after acquiring an additional 2,727 shares in the last quarter. 60.33% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Craig Hallum initiated coverage on shares of Indivior in a research report on Wednesday, April 3rd. They issued a “buy” rating and a $37.00 price objective on the stock.

Indivior Stock Up 0.1 %

Shares of NASDAQ:INDV traded up $0.02 during midday trading on Friday, reaching $17.95. The company had a trading volume of 96,887 shares, compared to its average volume of 125,006. Indivior PLC has a 1-year low of $14.38 and a 1-year high of $26.50. The stock has a market cap of $2.47 billion, a PE ratio of 1,795.00 and a beta of 0.63. The company has a quick ratio of 0.74, a current ratio of 0.92 and a debt-to-equity ratio of 23.50. The business’s 50 day moving average price is $20.38 and its 200 day moving average price is $18.23.

Indivior (NASDAQ:INDV) last posted its quarterly earnings results on Thursday, February 22nd. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.15. Indivior had a return on equity of 842.72% and a net margin of 0.44%. The firm had revenue of $293.00 million during the quarter, compared to the consensus estimate of $260.00 million. Research analysts forecast that Indivior PLC will post 2 EPS for the current fiscal year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.